Weight loss jabs could halve the number of sick days people take off work and significantly reduce the strain on the NHS , a study has found. Research showed that after nine months, patients prescribed the injections benefited from a significant boost to productivity, and their absence due to sickness dropped by 45 per cent, while long-term absences of five days or more reduced by 56 per cent. Researchers assessed 1,270 NHS patients on Oviva’s tier 3 weight management programme. The patients in the study were severely obese, with an average BMI of 45 at the start of the programme, falling to 39 after nine months. On average, they were managing at least three serious conditions when they joined the programme, most commonly anxiety, high blood pressure and Type 2 diabetes. Most of the patients were prescribed semaglutide, which is marketed as Wegovy for weight loss and Ozempic for the treatment of Type 2 diabetes.…